AstraZeneca announces vaccine effectiveness against Delta strain

AstraZeneca’s coronavirus vaccine has shown efficacy against strains Delta and Kappa, identified for the first time in India.

According to our data, the company said so in a press release.

As clarified in the publication, Oxford University has studied the ability of antibodies to neutralize these variants of the coronavirus.

As it became known, Pfizer and AstraZeneca vaccines provide more than 90% protection against hospitalization due to the Delta strain.